Inrebic

Celgene Corporation🇺🇸 United States

FDA Page

Effective Date: May 15, 2023
Approval ID: f0f55a2a-4e0c-4cba-8571-03e1424486d7
Products: 0 registered
Version: 8

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null, null], "sup": "®", "#text": "These highlights do not include all the information needed to use INREBIC safely and effectively. See full prescribing information for INREBIC. \n INREBIC (fedratinib) capsules, for oral use Initial U.S. Approval: 2019"}

Quick Stats

Total Products0

Labelers1

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.